NATCO Pharma Limited (NATCOPHARM.BO)
INR 775.35
(3.82%)
INR 775.35
(3.82%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 40.02 Billion INR | 48.27% |
| 2022 | 26.96 Billion INR | 41.58% |
| 2021 | 19.04 Billion INR | 12.7% |
| 2020 | 16.9 Billion INR | -10.46% |
| 2019 | 18.87 Billion INR | -8.44% |
| 2018 | 20.61 Billion INR | -4.4% |
| 2017 | 21.56 Billion INR | 8.1% |
| 2016 | 19.95 Billion INR | 87.63% |
| 2015 | 10.63 Billion INR | 29.89% |
| 2014 | 8.18 Billion INR | 11.83% |
| 2013 | 7.32 Billion INR | 12.62% |
| 2012 | 6.5 Billion INR | 25.64% |
| 2011 | 5.17 Billion INR | 12.56% |
| 2010 | 4.59 Billion INR | 6.71% |
| 2009 | 4.3 Billion INR | -0.04% |
| 2008 | 4.3 Billion INR | 31.49% |
| 2007 | 3.27 Billion INR | 35.7% |
| 2006 | 2.41 Billion INR | 43.69% |
| 2005 | 1.68 Billion INR | 8.87% |
| 2004 | 1.54 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 13.62 Billion INR | 27.55% |
| 2023 Q3 | 7.58 Billion INR | -26.45% |
| 2023 Q1 | 11.4 Billion INR | 28.48% |
| 2023 Q2 | 10.31 Billion INR | -9.57% |
| 2023 Q4 | 10.68 Billion INR | 40.83% |
| 2023 FY | 39.98 Billion INR | 48.27% |
| 2022 Q3 | 4.92 Billion INR | 13.98% |
| 2022 Q4 | 8.87 Billion INR | 80.24% |
| 2022 FY | 26.96 Billion INR | 41.58% |
| 2022 Q1 | 8.84 Billion INR | 58.84% |
| 2022 Q2 | 4.32 Billion INR | -51.15% |
| 2021 Q4 | 5.56 Billion INR | -0.64% |
| 2021 Q1 | 4.1 Billion INR | 1445.25% |
| 2021 FY | 19.04 Billion INR | 12.7% |
| 2021 Q2 | 3.77 Billion INR | -8.07% |
| 2021 Q3 | 5.6 Billion INR | 48.59% |
| 2020 Q1 | 5.63 Billion INR | 31.76% |
| 2020 Q2 | 8.02 Billion INR | 42.39% |
| 2020 Q3 | 3.55 Billion INR | -55.72% |
| 2020 Q4 | -305 Million INR | -108.59% |
| 2020 FY | 16.9 Billion INR | -10.46% |
| 2019 Q3 | 4.82 Billion INR | -0.72% |
| 2019 FY | 18.87 Billion INR | -8.44% |
| 2019 Q4 | 4.27 Billion INR | -11.32% |
| 2019 Q2 | 4.85 Billion INR | -1.34% |
| 2019 Q1 | 4.92 Billion INR | 16.38% |
| 2018 Q4 | 4.23 Billion INR | -24.02% |
| 2018 Q3 | 5.56 Billion INR | 2.43% |
| 2018 Q2 | 5.43 Billion INR | 0.91% |
| 2018 FY | 20.61 Billion INR | -4.4% |
| 2018 Q1 | 5.38 Billion INR | -29.85% |
| 2017 FY | 21.56 Billion INR | 8.1% |
| 2017 Q1 | 4.28 Billion INR | -24.19% |
| 2017 Q4 | 7.67 Billion INR | 36.57% |
| 2017 Q2 | 4.26 Billion INR | -0.33% |
| 2017 Q3 | 5.62 Billion INR | 31.76% |
| 2016 Q4 | 5.64 Billion INR | -15.7% |
| 2016 Q1 | 3.25 Billion INR | -17.55% |
| 2016 Q3 | 6.69 Billion INR | 45.54% |
| 2016 Q2 | 4.6 Billion INR | 41.54% |
| 2016 FY | 19.95 Billion INR | 87.63% |
| 2015 Q4 | 3.94 Billion INR | 43.33% |
| 2015 FY | 10.63 Billion INR | 29.89% |
| 2015 Q3 | 2.75 Billion INR | 16.35% |
| 2015 Q2 | 2.36 Billion INR | 9.65% |
| 2015 Q1 | 2.15 Billion INR | -8.22% |
| 2014 Q4 | 2.35 Billion INR | 27.53% |
| 2014 Q2 | 2.09 Billion INR | 9.75% |
| 2014 Q1 | 1.9 Billion INR | -12.27% |
| 2014 FY | 8.18 Billion INR | 11.83% |
| 2014 Q3 | 1.84 Billion INR | -11.86% |
| 2013 Q2 | 1.62 Billion INR | -0.99% |
| 2013 Q3 | 1.86 Billion INR | 14.28% |
| 2013 FY | 7.32 Billion INR | 12.62% |
| 2013 Q1 | 1.64 Billion INR | -10.45% |
| 2013 Q4 | 2.17 Billion INR | 16.62% |
| 2012 Q1 | 1.34 Billion INR | -16.91% |
| 2012 FY | 6.5 Billion INR | 25.64% |
| 2012 Q2 | 1.69 Billion INR | 25.8% |
| 2012 Q4 | 1.83 Billion INR | 16.46% |
| 2012 Q3 | 1.57 Billion INR | -6.73% |
| 2011 Q3 | 1.29 Billion INR | 2.1% |
| 2011 FY | 5.17 Billion INR | 12.56% |
| 2011 Q2 | 1.26 Billion INR | 0.0% |
| 2011 Q4 | 1.61 Billion INR | 25.15% |
| 2010 FY | 4.59 Billion INR | 6.71% |
| 2009 FY | 4.3 Billion INR | -0.04% |
| 2008 FY | 4.3 Billion INR | 31.49% |
| 2007 FY | 3.27 Billion INR | 35.7% |
| 2006 FY | 2.41 Billion INR | 43.69% |
| 2005 FY | 1.68 Billion INR | 8.87% |
| 2004 FY | 1.54 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 91.748% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -280.652% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -1443.719% |
| Achyut Healthcare Limited | 61.36 Million INR | -65112.078% |
| Ajanta Pharma Limited | 42.08 Billion INR | 4.911% |
| Alkem Laboratories Limited | 126.67 Billion INR | 68.408% |
| Alpa Laboratories Limited | 1.08 Billion INR | -3580.372% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | 34.523% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -208.908% |
| Aurobindo Pharma Limited | 287.04 Billion INR | 86.058% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -745.342% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -419.575% |
| Brooks Laboratories Limited | 794.86 Million INR | -4934.843% |
| Divi's Laboratories Limited | 78.45 Billion INR | 48.987% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 85.664% |
| Eris Lifesciences Limited | 20.09 Billion INR | -99.189% |
| FDC Limited | 19.42 Billion INR | -105.976% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 66.122% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | -75.279% |
| Granules India Limited | 45.06 Billion INR | 11.192% |
| Gufic Biosciences Limited | 8.06 Billion INR | -396.116% |
| Hester Biosciences Limited | 3.04 Billion INR | -1214.087% |
| Indoco Remedies Limited | 17.89 Billion INR | -123.644% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -212.437% |
| Ipca Laboratories Limited | 76.22 Billion INR | 47.497% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -1817.567% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -7837.09% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -3735.721% |
| Laurus Labs Limited | 50.01 Billion INR | 19.989% |
| Lupin Limited | 200.1 Billion INR | 80.001% |
| Mankind Pharma Limited | 103.34 Billion INR | 61.276% |
| Medicamen Biotech Limited | 1.79 Billion INR | -2131.936% |
| Medico Remedies Limited | 1.44 Billion INR | -2661.51% |
| Megasoft Limited | 373.95 Million INR | -10601.88% |
| Piramal Pharma Limited | 81.71 Billion INR | 51.023% |
| RPG Life Sciences Limited | 5.82 Billion INR | -587.57% |
| Sigachi Industries Limited | 3.98 Billion INR | -903.118% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -5197.484% |
| Unichem Laboratories Limited | 16.57 Billion INR | -141.46% |
| Wanbury Limited | 5.75 Billion INR | -595.214% |
| Windlas Biotech Limited | 6.3 Billion INR | -534.276% |
| ZIM Laboratories Limited | 3.67 Billion INR | -989.204% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 78.961% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -247.619% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -850.074% |
| Bal Pharma Limited | 3.39 Billion INR | -1079.767% |
| Strides Pharma Science Limited | 40.51 Billion INR | 1.213% |
| Venus Remedies Limited | 5.91 Billion INR | -576.643% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | -120.435% |
| Nectar Lifesciences Limited | 16.84 Billion INR | -137.636% |
| Shilpa Medicare Limited | 11.51 Billion INR | -247.516% |
| Aarti Drugs Limited | 25.28 Billion INR | -58.271% |
| IOL Chemicals and Pharmaceuticals Limited | 21.18 Billion INR | -88.866% |
| Suven Life Sciences Limited | 116.92 Million INR | -34125.898% |
| Ind-Swift Limited | 5.02 Billion INR | -696.468% |
| Valiant Laboratories Limited | 1.82 Billion INR | -2098.21% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.84 Billion INR | -14.862% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -223.162% |
| Themis Medicare Limited | 3.81 Billion INR | -948.3% |
| Hikal Limited | 17.84 Billion INR | -124.252% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 62.265% |
| Sequent Scientific Limited | 13.69 Billion INR | -192.174% |
| Novartis India Limited | 3.35 Billion INR | -1094.377% |
| Wockhardt Limited | 27.89 Billion INR | -43.492% |
| Jubilant Pharmova Limited | 67.02 Billion INR | 40.294% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -9896.178% |
| Neuland Laboratories Limited | 15.58 Billion INR | -156.772% |
| Morepen Laboratories Limited | 17.01 Billion INR | -135.149% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -2492.431% |
| Mangalam Drugs & Organics Limited | 3.68 Billion INR | -985.745% |